Showing: Press Releases
Press Releases / In The Media
LAVVAN files a $881 million patent infringement...
Today, LAVVAN filed a $881 million patent infringement and trade secret misappropriation lawsuit against Amyris, Inc. in the United States District Court for the Southern District of New York (docket […]
LAVVAN Appoints Neil Closner as Chief Executive...
Former MedReleaf executive team joins Closner in transformative venture to drive cannabinoid fermentation efforts NEW YORK, NY – August 8, 2019: LAVVAN Inc. (“LAVVAN”) today announced that Neil Closner, formerly […]
Amyris Finalizes Cannabinoid Development, Licensing and Commercialization...
LAVVAN Cites Amyris’s Proven Commercial Achievements and Capability to Bring to Market the Highest Quality Cannabinoids for Large Scale Use EMERYVILLE, Calif., March 18, 2019 (GLOBE NEWSWIRE) — Amyris, Inc. […]